Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the ...

Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity ...

The Australian AI predictions platform that called four out of five underdogs in the NBA Finals has landed on American soil - and it's locked in for the NFL.

Alerts escalate through the on-call rotation until someone answers. Free for up to five users, with paid plans starting at USD $6 per user per month. On-call ...

Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...

The next generation in skin resurfacing technology is available to Australian health care practitioners beginning 1 September ...

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day ...

TwoTen Ballarat Pty Ltd ACN 653 946 760 (the Issuer) is seeking to raise a total of AUD 48,055,484 in funds by the issue of loan notes, according to an announcement today by the underwriter Banner ...

FNArena provides a weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX in the form of a comparables table, courtesy to Vested Equities/Banyantree ...

AI data centre infrastructure's burgeoning energy needs strengthen the long-term uranium outlook, while Boss and Paladin face contrasting operational, funding and valuation challenges ...

September is historically the weakest month for stocks, and on average the S&P500 falls -1.1%. The Australian market eased on Monday but clocked up a 1% gain in August. ASX200 futures are pointing to ...